Method for determining risk of obesity in vitro
An in-vivo and in-vitro detection technology, applied in the determination/inspection of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc., can solve the problems of no significant correlation, different correlations, inaccurate obesity risk, etc., and achieve obesity The risk-enhancing effect of
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0042] Materials and Methods
[0043]
[0044] This trial invites Taiwanese adults to participate through the Department of Family Medicine and Community Medicine Center of Mackay Memorial Hospital, and excludes those who are currently pregnant, cancer, secondary obesity, obesity caused by congenital chromosomal abnormalities (such as Prader-WilliSyndrome), and taking weight-loss drugs or those who have undergone bariatric surgery. The 587 subjects who participated in the experiment were divided into normal groups (323 persons, BMI2 ) and obesity group (264 people, BMI≧27kg / m 2 ). All subjects are required to agree to sign the human experiment consent form, and record their age, gender, height, weight, waist and hip circumference, body fat percentage, blood pressure, heartbeat and other data. The contents of the test were all reviewed and approved by the Mackay Hospital Human Test Committee (IRB).
[0045]
[0046] Peripheral venous blood (about 3-5c.c) was collected fr...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


